Ljubljana

From 2007.igem.org

(Difference between revisions)
(Project in brief)
(ACKNOWLEDGEMENTS)
Line 51: Line 51:
Our team would like to thank for the financial support to the organizations that made our research and attendance of the jamboree possible:
Our team would like to thank for the financial support to the organizations that made our research and attendance of the jamboree possible:
-
AdFutura public fund,  
+
AdFutura Public Fund,  
Ministry of High Scool Education, Science and Technology of Slovenia,  
Ministry of High Scool Education, Science and Technology of Slovenia,  
University of Ljubljana,  
University of Ljubljana,  
Slovenian Biochemical Society,  
Slovenian Biochemical Society,  
-
European Commission and Synbiocomm project,  
+
European Commission - Synbiocomm Project,  
-
National institute of Chemistry.
+
National Institute of Chemistry,
 +
Lek - a Sandoz company.
[[Image:logo_glava_AdFutura.gif]]
[[Image:logo_glava_AdFutura.gif]]
Line 63: Line 64:
[[Image:SBDLogoS.jpg]]
[[Image:SBDLogoS.jpg]]
[[Image:120px-EU-flag.gif]]
[[Image:120px-EU-flag.gif]]
 +
[[Image:Lek-logo.jpg]]
Special thanks are due to GeneArt for the support in synthesis of parts:
Special thanks are due to GeneArt for the support in synthesis of parts:
[[Image:GeneArt.jpg]]
[[Image:GeneArt.jpg]]

Revision as of 07:22, 12 October 2007

Contents

Project in brief

Last year our team modified human cells by introducing a feedback device with a dominant-negative inhibitor under the control of the NFkapaB promotor, which decreased the damaging excessive response to the bacterial infection. In 2007, we are remaining in the domain of the potential applications of synthetic biology to improve human health.

The goal of our project is to design cells that will be able to detect the invasion of a pathogen and defend the organism by either undergoing apoptosis (and destroying the invaded pathogen before it can replicate) or by mounting any other defense response. To our opinion, the main innovative aspect of the project will be to detect the invasion of the pathogen not based on any particular sequence (which can be avoided through point mutations of the pathogen) but rather by relying on the function of the pathogen, which is essential for its survival or pathogenicity. The ultimate goal of this approach would be to develop gene therapy against infectious diseases.

In parallel with the research, we prepared a 12-pages brochure on Synthetic Biology and our project in Slovenian language, aimed at life science students and general audience.

Slovenian iGEM2007 team

Team2-small.jpg

Ljubljana team in June 2007 (photo taken in the new meeting room at the [http://www.ki.si/index.php?id=117&no_cache=1&L=1 Natl. Institute of Chemistry]).
First row: Saša, Mojca, Katja, Anja, Nives; Second row: Roman, Mateja, Karolina, Gabi, Peter, Andrej, Rok, Marko D. (missing on the photo is Marko B.)


undergraduate students:
Marko Bitenc - Biotechnology 3rd year
Peter Cimermančič - Biochemistry 3rd year
Rok Gaber - Microbiology 3rd year
Saša Jereb - Biochemistry 2nd year
Katja Kolar - Biochemistry 2nd year
Anja Korenčič - Biochemistry 4th year
Andrej Ondračka - Biochemistry 3rd year

instructors:
Roman Jerala - NIC - supervisor
Marko Dolinar - FCCT - supervisor
Mojca Benčina - NIC
Karolina Ivičak - NIC
Mateja Manček Keber - NIC
Gabriela Panter - NIC
Nives Škrlj - FCCT


Ljubljana and hosting institutions

[http://www.ljubljana.si/en/ljubljana/ Ljubljana] (population 300.000) is the capital of [http://www.slovenia.si/ Slovenia] (population 2 million) and homes the largest of three universities in the country, [http://www.uni-lj.si University of Ljubljana] (UL). Most of the research work will be done at the [http://www.ki.si/index.php?id=117&no_cache=1&L=1 National Institute of Chemistry], [http://www.ki.si/index.php?id=192&no_cache=1&L=1 Laboratory of Biotechnology] and parts of it at the UL [http://www.fkkt.uni-lj.si/en/ Faculty of Chemistry and Chemical Technology], [http://openwetware.org/wiki/FCCT_Biochemistry_Lab Biochemistry Chair].


iGEM 2006 project

Ljubljana team joined iGEM in 2006 and received the grand prize! The project focused on the signal transduction linked to development of sepsis. We engineered a negative feedback loop that inhibited excessive signalling via toll-like receptors. For more information, check the 2006 wiki or follow Alja's [http://partsregistry.org/movies/iGEM2006_ljubljana.mov presentation] at the Jamboree. We were also invited to [http://download.podcast.ethz.ch/media/MAVT-0001-00X/2007062409_dm.m4v present] our work at the 2007 SB 3.0 conference in Zurich.


ACKNOWLEDGEMENTS

Our team would like to thank for the financial support to the organizations that made our research and attendance of the jamboree possible: AdFutura Public Fund, Ministry of High Scool Education, Science and Technology of Slovenia, University of Ljubljana, Slovenian Biochemical Society, European Commission - Synbiocomm Project, National Institute of Chemistry, Lek - a Sandoz company.

Logo glava AdFutura.gif KIlogo.gif Menuleft logo unilj.gif SBDLogoS.jpg 120px-EU-flag.gif Lek-logo.jpg

Special thanks are due to GeneArt for the support in synthesis of parts:

GeneArt.jpg